{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:23:38Z","timestamp":1777026218418,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nasal route drug administration for local and systemic delivery of many therapeutics has received attention because the nasal cavity is highly vascularized and provides a large surface area for drug absorption. However, nasal mucosa exhibits limited permeability to polar molecules. In this study, we developed a novel method for improving absorption efficiency of polar drugs by applying hypergravity. RPMI 2650 cells and primary human nasal epithelial cells were exposed three times to a 20\u2009min hypergravitational condition (10\u2009\u00d7\u2009<jats:italic>g<\/jats:italic>) with a 20\u2009min rest period after each exposure. The applied hypergravity induced a decrease in transepithelial electrical resistance without significant loss of cellular metabolic activity, and cellular permeability of fluorescein sodium salt (MW 376\u2009Da; NaFI) and FITC-labeled dextran (average MW 4,000\u2009Da; FD-4) increased by 19% and 16%, respectively. Immunostaining and RT-qPCR results demonstrated that hypergravity conditions affected cytoskeletal structures and tight junctions, leading to weakening of the cell barrier function and increasing the cellular permeability of polar molecules. Our results indicate that hypergravity could be used as a new strategy for enhancing the efficiency of drug absorption via the nasal route.<\/jats:p>","DOI":"10.1038\/s41598-017-18561-x","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T15:26:37Z","timestamp":1514993197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity"],"prefix":"10.1038","volume":"8","author":[{"given":"Dongjoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5324-2711","authenticated-orcid":false,"given":"Soonjo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"18561_CR1","first-page":"14","volume":"5","author":"SL Patwekar","year":"2013","unstructured":"Patwekar, S. L., Gattani, S. G. & Pande, M. M. Needle free injection system: A review. Int. J. Pharm. Pharm. Sci. 5, 14\u201319 (2013).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"18561_CR2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz, M. R. & Langer, R. Transdermal drug delivery. Nat. Biotechnol. 26, 1261\u20131268 (2008).","journal-title":"Nat. Biotechnol."},{"key":"18561_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"PG Djupesland","year":"2013","unstructured":"Djupesland, P. G. Nasal drug delivery devices: Characteristics and performance in a clinical perspective-a review. Drug Deliv. Transl. Res. 3, 42\u201362 (2013).","journal-title":"Drug Deliv. Transl. Res."},{"key":"18561_CR4","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1517\/17425247.2015.1049531","volume":"12","author":"NC Hogan","year":"2015","unstructured":"Hogan, N. C., Taberner, A. J., Jones, L. A. & Hunter, I. W. Needle-free delivery of macromolecules through the skin using controllable jet injectors. Expert Opin. Drug Deliv. 12, 1637\u20131648 (2015).","journal-title":"Expert Opin. Drug Deliv."},{"key":"18561_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/2230-973X.167662","volume":"5","author":"AD Ravi","year":"2015","unstructured":"Ravi, A. D., Sadhna, D., Nagpaal, D. & Chawla, L. Needle free injection technology: A complete insight. Int. J. Pharm. Investig. 5, 192\u2013199 (2015).","journal-title":"Int. J. Pharm. Investig."},{"key":"18561_CR6","first-page":"110","volume":"3","author":"MU Ghori","year":"2015","unstructured":"Ghori, M. U., Mahdi, M. H., Smith, A. M. & Conway, B. R. Nasal Drug Delivery Systems: An Overview. Am. J. Pharmacol. Sci. 3, 110\u2013119 (2015).","journal-title":"Am. J. Pharmacol. Sci."},{"key":"18561_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/10611869308996066","volume":"1","author":"AS Harris","year":"1993","unstructured":"Harris, A. S. Review: Clinical opportunities provided by the nasal administration of peptides. J. Drug Target. 1, 101\u2013116 (1993).","journal-title":"J. Drug Target."},{"key":"18561_CR8","first-page":"610","volume":"4","author":"Z Patel","year":"2012","unstructured":"Patel, Z., Patel, B., Patel, S. & Pardeshi, C. Nose to brain targeted drug delivery bypassing the blood-brain barrier: An overview. Drug Invent. Today 4, 610\u2013615 (2012).","journal-title":"Today"},{"key":"18561_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi, C. V. & Belgamwar, V. S. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin. Drug Deliv. 10, 957\u2013972 (2013).","journal-title":"Expert Opin. Drug Deliv."},{"key":"18561_CR10","first-page":"6","volume":"37","author":"V Agarwal","year":"1999","unstructured":"Agarwal, V. & Mishra, B. Recent trends in drug delivery systems: Intranasal drug delivery. Indian J. Exp. Biol. 37, 6\u201316 (1999).","journal-title":"Indian J. Exp. Biol."},{"key":"18561_CR11","doi-asserted-by":"crossref","unstructured":"Hanson, L. R. & Frey I., W. H. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 9 (2008).","DOI":"10.1186\/1471-2202-9-S3-S5"},{"key":"18561_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum, L. Nasal drug delivery - possibilities, problems and solutions. J. Control. Release 87, 187\u2013198 (2003).","journal-title":"J. Control. Release"},{"key":"18561_CR13","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2174\/138920112803341752","volume":"13","author":"A Misra","year":"2012","unstructured":"Misra, A. & Kher, G. Drug delivery systems from nose to brain. Curr. Pharm. Biotechnol. 13, 2355\u20132379 (2012).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"18561_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","volume":"7","author":"L Illum","year":"2002","unstructured":"Illum, L. Nasal drug delivery: new developments and strategies. Drug Discov. Today 7, 1184\u20131189 (2002).","journal-title":"Drug Discov. Today"},{"key":"18561_CR15","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1083\/jcb.101.6.2124","volume":"101","author":"JL Madara","year":"1985","unstructured":"Madara, J. L. & Dharmsathaphorn, K. Occluding junction structure-function relationships in a cultured epithelial monolayer. J. Cell Biol. 101, 2124\u20132133 (1985).","journal-title":"J. Cell Biol."},{"key":"18561_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-3565(25)24258-6","volume":"244","author":"BJ Aungst","year":"1988","unstructured":"Aungst, B. J., Rogers, N. J. & Shefter, E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J. Pharmacol. Exp. Ther. 244, 23\u201327 (1988).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"18561_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/jir.1990.10.497","volume":"10","author":"C Baglioni","year":"1990","unstructured":"Baglioni, C. & Phipps, R. J. Nasal absorption of interferon: enhancement by surfactant agents. J. Interferon Res. 10, 497\u2013504 (1990).","journal-title":"J. Interferon Res."},{"key":"18561_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1464-5491.1992.tb01792.x","volume":"9","author":"K Drejer","year":"1992","unstructured":"Drejer, K. et al. Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabet. Med. 9, 335\u2013340 (1992).","journal-title":"Diabet. Med."},{"key":"18561_CR19","first-page":"588","volume":"8","author":"FWHM Merkus","year":"1991","unstructured":"Merkus, F. W. H. M., Verhoef, J. C., Romeijn, S. G. & Schipper, N. G. M. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci. 8, 588\u2013592 (1991).","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci."},{"key":"18561_CR20","first-page":"1186","volume":"11","author":"L Illum","year":"1994","unstructured":"Illum, L., Farraj, N. F. & Davis, S. S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci. 11, 1186\u20131189 (1994).","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci."},{"key":"18561_CR21","first-page":"227","volume":"6","author":"M Quadir","year":"1999","unstructured":"Quadir, M., Zia, H. & Needham, T. E. Toxicological implications of nasal formulations. Drug Deliv. J. Deliv. Target. Ther. Agents 6, 227\u2013242 (1999).","journal-title":"Drug Deliv. J. Deliv. Target. Ther. Agents"},{"key":"18561_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S1461-5347(98)00100-X","volume":"1","author":"HE Junginger","year":"1998","unstructured":"Junginger, H. E. & Verhoef, J. C. Macromolecules as safe penetration enhancers for hydrophilic drugs - a fiction? Pharm. Sci. Technol. Today 1, 370\u2013376 (1998).","journal-title":"Pharm. Sci. Technol. Today"},{"key":"18561_CR23","doi-asserted-by":"publisher","first-page":"C566","DOI":"10.1152\/ajpcell.00418.2006","volume":"293","author":"WK Sumanasekera","year":"2007","unstructured":"Sumanasekera, W. K. et al. Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity. Am. J. Physiol. - Cell Physiol. 293, C566\u2013C573 (2007).","journal-title":"Am. J. Physiol. - Cell Physiol."},{"key":"18561_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00441-005-0113-0","volume":"324","author":"WK Sumanasekera","year":"2006","unstructured":"Sumanasekera, W. K. et al. Effect of estradiol and dihydrotestosterone on hypergravity-induced MAPK signaling and occludin expression in human umbilical vein endothelial cells. Cell Tissue Res. 324, 243\u2013253 (2006).","journal-title":"Cell Tissue Res."},{"key":"18561_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0091-6749(83)90518-3","volume":"72","author":"N Geurkink","year":"1983","unstructured":"Geurkink, N. Nasal anatomy, physiology, and function. J. Allergy Clin. Immunol. 72, 123\u2013128 (1983).","journal-title":"J. Allergy Clin. Immunol."},{"key":"18561_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0037-1598055","volume":"33","author":"RG Patel","year":"2017","unstructured":"Patel, R. G. Nasal Anatomy and Function. Facial Plast. Surg. 33, 3\u20138 (2017).","journal-title":"Facial Plast. Surg."},{"key":"18561_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000321044","volume":"40","author":"C Bitter","year":"2011","unstructured":"Bitter, C., Suter-Zimmermann, K. & Surber, C. Nasal drug delivery in humans. Current Problems in Dermatology 40, 20\u201335 (2011).","journal-title":"Current Problems in Dermatology"},{"key":"18561_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/btpr.558","volume":"27","author":"SK Ling","year":"2011","unstructured":"Ling, S. K. et al. Pretreatment of rat bone marrow mesenchymal stem cells with a combination of hypergravity and 5-azacytidine enhances therapeutic efficacy for myocardial infarction. Biotechnol. Prog. 27, 473\u2013482 (2011).","journal-title":"Biotechnol. Prog."},{"key":"18561_CR29","doi-asserted-by":"crossref","unstructured":"Genchi, G. G. et al. Hypergravity stimulation enhances PC12 neuron-like cell differentiation. Biomed Res. Int. 2015 (2015).","DOI":"10.1155\/2015\/748121"},{"key":"18561_CR30","doi-asserted-by":"crossref","unstructured":"Zhou, S., Zu, Y., Sun, Z., Zhuang, F. & Yang, C. Effects of hypergravity on osteopontin expression in osteoblasts. PLoS One 10 (2015).","DOI":"10.1371\/journal.pone.0128846"},{"key":"18561_CR31","doi-asserted-by":"crossref","unstructured":"Jang, T. Y., Jung, A. Y. & Kim, Y. H. Hormetic Effect of Chronic Hypergravity in a Mouse Model of Allergic Asthma and Rhinitis. Sci. Rep. 6 (2016).","DOI":"10.1038\/srep27260"},{"key":"18561_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/1097-0142(196402)17:2<170::AID-CNCR2820170206>3.0.CO;2-N","volume":"17","author":"GE Moore","year":"1964","unstructured":"Moore, G. E. & Sandberg, A. A. Studies of a Human Tumor Cell Line With a Diploid Karyotype. Cancer 17, 170\u20135 (1964).","journal-title":"Cancer"},{"key":"18561_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0014-4827(65)90022-4","volume":"39","author":"PS Moorhead","year":"1965","unstructured":"Moorhead, P. S. Human tumor cell line with a quasi-diploid karyotype (RPMI 2650). Exp. Cell Res. 39, 190\u2013196 (1965).","journal-title":"Exp. Cell Res."},{"key":"18561_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jps.21031","volume":"97","author":"S Bai","year":"2008","unstructured":"Bai, S., Yang, T., Abbruscato, T. J. & Ahsan, F. Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies. J. Pharm. Sci. 97, 1165\u20131178 (2008).","journal-title":"J. Pharm. Sci."},{"key":"18561_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10616-012-9493-7","volume":"65","author":"L K\u00fcrti","year":"2013","unstructured":"K\u00fcrti, L. et al. Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability. Cytotechnology 65, 395\u2013406 (2013).","journal-title":"Cytotechnology"},{"key":"18561_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejpb.2009.08.008","volume":"74","author":"A Wengst","year":"2010","unstructured":"Wengst, A. & Reichl, S. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies. Eur. J. Pharm. Biopharm. 74, 290\u2013297 (2010).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"18561_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11095-014-1494-0","volume":"32","author":"ME Kreft","year":"2015","unstructured":"Kreft, M. E. et al. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharm. Res. 32, 665\u2013679 (2015).","journal-title":"Pharm. Res."},{"key":"18561_CR38","doi-asserted-by":"crossref","unstructured":"Saunders, N. R., Dziegielewska, K. M., M\u00f8llg\u00e5rd, K. & Habgood, M. D. Markers for blood-brain barrier integrity: How appropriate is Evans blue in the twenty-first century and what are the alternatives? Front. Neurosci. 9 (2015).","DOI":"10.3389\/fnins.2015.00385"},{"key":"18561_CR39","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/BF01990088","volume":"39","author":"A Tschopp","year":"1983","unstructured":"Tschopp, A. & Cogoli, A. Hypergravity promotes cell proliferation. Experientia 39, 1323\u20131329 (1983).","journal-title":"Experientia"},{"key":"18561_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00424-008-0544-z","volume":"457","author":"T Koyama","year":"2009","unstructured":"Koyama, T. et al. Hypergravity induces ATP release and actin reorganization via tyrosine phosphorylation and RhoA activation in bovine endothelial cells. Pflugers Arch. Eur. J. Physiol. 457, 711\u2013719 (2009).","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"18561_CR41","first-page":"126","volume":"16","author":"JM Anderson","year":"2001","unstructured":"Anderson, J. M. Molecular structure of tight junctions and their role in epithelial transport. News Physiol. Sci. 16, 126\u2013130 (2001).","journal-title":"News Physiol. Sci."},{"key":"18561_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00418-015-1351-1","volume":"144","author":"S Chen","year":"2015","unstructured":"Chen, S., Einspanier, R. & Schoen, J. Transepithelial electrical resistance (TEER): a functional parameter to monitor the quality of oviduct epithelial cells cultured on filter supports. Histochem. Cell Biol. 144, 509\u2013515 (2015).","journal-title":"Histochem. Cell Biol."},{"key":"18561_CR43","doi-asserted-by":"publisher","first-page":"C148","DOI":"10.1152\/ajpcell.00524.2003","volume":"289","author":"ND Searby","year":"2005","unstructured":"Searby, N. D., Steele, C. R. & Globus, R. K. Influence of increased mechanical loading by hypergravity on the microtubule cytoskeleton and prostaglandin E2 release in primary osteoblasts. Am. J. Physiol. Cell Physiol. 289, C148\u2013C158 (2005).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"18561_CR44","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","volume":"1778","author":"A Hartsock","year":"2008","unstructured":"Hartsock, A. & Nelson, W. J. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta - Biomembr. 1778, 660\u2013669 (2008).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"18561_CR45","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.bbamcr.2007.05.014","volume":"1773","author":"S Versari","year":"2007","unstructured":"Versari, S., Villa, A., Bradamante, S. & Maier, J. A. M. Alterations of the actin cytoskeleton and increased nitric oxide synthesis are common features in human primary endothelial cell response to changes in gravity. Biochim. Biophys. Acta - Mol. Cell Res. 1773, 1645\u20131652 (2007).","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"18561_CR46","doi-asserted-by":"crossref","unstructured":"Jones, J. C. R. Reduction of contamination of epithelial cultures by fibroblasts. Cold Spring Harb. Protoc. 3 (2008).","DOI":"10.1101\/pdb.prot4478"},{"key":"18561_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18561-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T10:22:54Z","timestamp":1751192574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18561-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18561"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18561-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"168"}}